Martin Jenkins Selected Research

fostamatinib

9/2017

Repeatability and response to therapy of dynamic contrast-enhanced magnetic resonance imaging biomarkers in rheumatoid arthritis in a large multicentre trial setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Jenkins Research Topics

Disease

20	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 09/2011
2	Lung Diseases (Lung Disease) 08/2021 - 04/2012
2	Dyspnea (Shortness of Breath) 08/2021 - 04/2012
2	Inflammation (Inflammations) 09/2017 - 09/2011
2	Neoplasms (Cancer) 05/2013 - 07/2010
1	Synovitis 09/2017
1	Rheumatoid Arthritis 09/2017
1	Disease Progression 04/2012
1	Respiratory Signs and Symptoms 04/2012
1	Cough 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 07/2010

Drug/Important Bio-Agent (IBA)

15	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 04/2012
13	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2018
8	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 04/2012
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2021
6	Muscarinic AntagonistsIBA 10/2021 - 01/2019
5	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 10/2021 - 01/2021
5	Bronchodilator Agents (Bronchodilators)IBA 05/2020 - 04/2012
4	Biomarkers (Surrogate Marker)IBA 09/2017 - 09/2011
3	SuspensionsIBA 01/2020 - 01/2018
2	GoldIBA 01/2020 - 08/2013
1	2- n- butyl- 3- (dimethylamino)- 5,6- methylenedioxyindeneIBA 05/2020
1	Adalimumab (Humira)FDA Link 09/2017
1	fostamatinibIBA 09/2017
1	Secretory Proteinase Inhibitory ProteinsIBA 04/2012
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2012
1	N- ((5- (methanesulfonyl)pyridin- 2- yl)methyl)- 6- methyl- 5- (1- methyl- 1H- pyrazol- 5- yl)- 2- oxo- 1- (3- (trifluoromethyl)phenyl)- 1,2- dihydropyridine- 3- carboxamideIBA 04/2012
1	Biological ProductsIBA 09/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2010
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2010
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 07/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2010
1	AntibodiesIBA 07/2010

Therapy/Procedure

14	Therapeutics 01/2022 - 07/2010
10	Metered Dose Inhalers (Metered Dose Inhaler) 01/2022 - 01/2018
1	Dry Powder Inhalers 01/2022